Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Free Newsletter Sign Up

Allergan Breast Implant Cancer Suits Head for New Jersey

Dec. 18, 2019, 4:27 PM

Federal lawsuits linking Allergan Inc.‘s textured Biocell breast implants with a rare cancer will be combined and sent to New Jersey, where the company is headquartered, a special panel ruled Dec. 18.

Allergan recalled the implants in July after the Food and Drug Administration said the products had been associated with breast implant-associated anaplastic large cell lymphoma, a cancer of the immune system.

The lawsuits followed soon after. Women allege Allergan failed to disclose a link between the implants and the immune system cancer, and offered an insufficient program to cover medical costs.

The suits share complex fact questions ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.